arrow
Back
Y

Yi‐Long Wu

southern medical university

135H-index
2.2KPaper Count
11.2WCitation Count
Published Papers 484
Publication Date
Neoadjuvant retlirafusp alfa (anti-PD-L1/TGF-β bifunctional fusion protein) with or without chemotherapy in unresectable stage III non-small cell lung cancer: updated results from the phase 2 TRAILBLAZER trial
err2026-06-16
err0
errOAAI
errYi Pan; Xuening Yang; Qing Zhou; Yanqiu Zhao; Guang Han; Qingsong Pang; Zhenfa Zhang; Qifeng Wang; Jun Yao; Hui Wang; Weihua Yang; Baogang Liu; Qixun Chen; Xianghui Du; Kaican Cai; Baosheng Li; Yunchao Huang; Xiao Li; Yijun Jia; Li Song; Wei Shi; Yi-Long Wu
errShare
errSave
Circulating tumor DNA analysis in lung cancer: from molecular origins to analytical boundaries
err2026-05-29
err0
errOAAI
errJia-Tao Zhang; Bai-Xin Lin; Xin-Guang Zhao; Wen-Zhao Zhong; Yi-Long Wu
errShare
errSave
Exploratory Identification of Gene Copy Number Cut-Off for NGS-Based <em>MET</em> Amplification Assessment and Clinical Relevance to MET Inhibitor Outcomes in Non-Small-Cell Lung Cancer
err2026-05-08
err0
errOAAI
errSi-Yang Maggie Liu; Zhi Xie; Lixu Yan; Guang-Ling Jie; Jia-Yi Deng; Qingling Zhang; Zhan Huang; Jin Wang; Zhou Zhang; Yang Shao; Hao Meng; Yan Zhang; Xu-Chao Zhang; Hua-Jun Chen; Wen-Zhao Zhong; Qing Zhou; Yi-Long Wu
errShare
errSave
Cardiovascular adverse events in non-small cell lung cancer patients receiving osimertinib therapy: a systematic review and meta-analysis
err2026-04-15
err0
PREAI
errWei-He Liu; Yun-Jiu Cheng; Jin Kang; Jian Chen; Zhen-Jie An; Ting-Hui Li; Ning Tan; Wen-Zhao Zhong; Yi-Long Wu; Lei Jiang
errShare
errSave
Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial
err2026-03-27
err0
errOAAI
errByoung Chul Cho; Rama Balaraman; Hua-Jun Chen; Xinmin Yu; Adewale Fawole; Zhi-gang Liu; Jiliang Zhang; Long Wu; Bin Yang; Jennifer L. Leddon; John Hamm; Yanjing Huang; Lin Wu; Pinhua Pan; Preet Singh; Andrew Beardsley; Fadi Kayali; Ardalan Davarifar; Ki Hyeong Lee; Keon-Uk Park; Youngjoo Lee; Luchun Li; Xicheng Wang; Meili Sun; Yan Yu; Vikram Jain; Svetlana Shpyro; Qiong Wang; Michael Wenger; Uğur Şahin; Sergey Efuni; Shiling Song; Kun He; Pan Zheng; Yang Liu; Kai He; Tianhong Li; Mark A. Socinski; Yi-Long Wu
errShare
errSave
Plain language summary of the ALINA study results: alectinib compared with chemotherapy after surgery in people with ALK-positive non-small cell lung cancer
err2025-12-31
err0
PREAI
errWu, Yi-Long; Dziadziuszko, Rafal; Ahn, Jin Seok; Barlesi, Fabrice; Nishio, Makoto; Lee, Dae Ho; Lee, Jong-Seok; Zhong, Wenzhao; Horinouchi, Hidehito; Mao, Weimin; Hochmair, Maximilian; De Marinis, Filippo; Migliorino, Maria Rita; Bondarenko, Igor; Lu, Shun; Wang, Qun; Lohmann, Tania Ochi; Xu, Tingting; Cardona, Andres; Hiles, Laura; Noe, Johannes; Solomon, Benjamin J.
errShare
errSave
Comparison of survival outcomes between sublobar resection and lobectomy in pathological stage IA pulmonary invasive mucinous adenocarcinoma
err2025-12-13
err0
errOAAI
errZhen-Bin Qiu; Hong-Ji Li; Jia-Yan Ding; Chao Zhang; Jin-Hai Yan; Fang-Ping Xu; Yi-Long Wu; Wen-Zhao Zhong; Ben-Yuan Jiang
errShare
errSave
PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy
err2025-12-07
err0
errOAAI
errYi-Long Wu; Lin Wu; Nan Bi; Timucin Cil; Hong Ge; Zhengfei Zhu; Chih-Liang Wang; Wei Zhang; Dongqing Lv; E. Mingyan; Jianguo Sun; Yi Pan; Maciej Krzakowski; Mustafa Dikilitas; Mehmet Ali Nahit Sendur; Young-Chul Kim; Yanjiao Yang; Rui Mao; Biao Zhang; Luhua Wang
errShare
errSave
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study
err2025-12-06
err0
PREAI
errYi-Long Wu; Yu Yao; Jin-Ji Yang; Lin Wu; Wei Zhang; Ying Wang; Hai-Peng Xu; Yong Song; Yan Zhang; Jun Zhao; Jing-Hua Chen; Zhe-Hai Wang; Qi-Ming Wang; Jie Hu; Xing-Ya Li; Yun Fan; Yuan Chen; Jian Fang; Di Han; Wei-Zhe Xue
errShare
errSave
Five-year outcomes of pembrolizumab versus chemotherapy in Chinese patients with non-small-cell lung cancer and programmed cell death ligand 1 tumor proportion score ≥1%: KEYNOTE-042 China study
err2025-12-01
err0
errOAAI
errWu, Yi-Long; Zhang, Li; Fan, Yun; Zhou, Jianying; Zhou, Qing; Li, Wei; Hu, Chengping; Chen, Gongyan; Zhang, Xin; Zhou, Caicun; Arenas, Carmen Gonzalez; Chen, Zhenghong; Yu, Wen Cheng; Mok, Tony S. K.
errShare
errSave
Real-world use of and clinical outcomes with dacomitinib as first-line therapy in Asian patients with EGFR mutation–positive locally advanced or metastatic non-small cell lung cancer: Final analysis of the ARIA study
err2025-11-25
err0
PREAI
errLin Wu; Junling Li; Chong-Rui Xu; Bivas Biswas; Somnath Roy; Ke-Jing Tang; Huijuan Wang; Ziling Liu; Ullas Batra; Gwo Fuang Ho; John Low Seng Hooi; You Lu; Mingfang Zhao; Lye Mun Tho; Jun Zhao; Shan He; Joan Huang; Hui Zhang; Chew Hooi Wong; Yi-Long Wu
errShare
errSave
errShare
errSave
High-performance ZnZrO x supported CuNi catalysts for CO 2 hydrogenation to methanol
err2025-10-16
err0
PREAI
errZhi Sheng Shi; Chaofan Liu; Yilong Wu; Nannan Ge; Xue-Ling Wei; Linhua Chu; Xingyang Li; Mei Xiang
errShare
errSave
Phafin2 modulates the aggregation of NLRP3 on dispersed trans-Golgi network
err2025-10-13
err0
PREAI
errYurou Li; Kaiyong Zheng; Chunsheng Chen; Yi Wu; Shuai Li; Weihong Zhou; Xinqi Liu
errShare
errSave
Preparation and characterization of DeSC modified using succinic anhydride
err2025-09-19
err0
PREAI
errWangda Lu; Yi Wu; Xuepeng Zhang; Xiaoran Sun; Hongzhou Shang
errShare
errSave
Establishing the China–UK Cancer Prevention and Control Alliance
err2025-09-01
err0
PREAI
errJun Ma; David Kerr; Yuankai Shi; Charles Swanton; Tony Mok; Rebecca Fitzgerald; Rui-Hua Xu; Richard Cowan; Rong Lin; Mark Lawler; Gao-Jun Teng; Tim Eisen; Molly Li; Maria Kyrgiou; Fanny Wai San Ko; Mark Middleton; Binghe Xu; Eric Aboyage; Dan Xiao; Yi-Long Wu; Arnie Puroshotham; Li Yang; Daiming Fan
errShare
errSave